Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
about
Involvement of the Androgen and Glucocorticoid Receptors in Bladder CancerInsidious changes in stromal matrix fuel cancer progressionThe wound healing, chronic fibrosis, and cancer progression triadDeletion of SPARC Enhances Retinal Vaso-Obliteration in Mouse Model of Oxygen-Induced Retinopathy.Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.Modelling bladder cancer in mice: opportunities and challenges.SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As+3- and Cd+2-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARCElevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer.Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model.Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.Roles of SPARC in urothelial carcinogenesis, progression and metastasis.Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.Epigenetic basis of cancer health disparities: Looking beyond genetic differences.Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.Racial health disparities in ovarian cancer: not just black and white.The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer.SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
P2860
Q26782760-4A90334E-8626-48DB-82C6-69D266A71FE9Q26851261-201F026B-3433-41AF-A8CE-3684F3F69350Q27014616-ED839CAF-C672-44D2-89DE-F19959BA7745Q30277965-7BC5D8EB-CD5A-44AE-9E98-56CF488301EBQ30279180-F358D1FC-0097-45AD-AA1D-77594FF42DEEQ34410598-03710DC8-9C71-4CE5-9C04-D5EE1E1209D8Q34766640-F61F3616-B605-4AAB-ACC8-43D3950AE938Q35285703-A4DF29BB-08DB-439F-9FB6-76B2D844390AQ35897462-9EC7A6EE-696E-4B5B-BD8C-91E570E081BFQ36640681-465368A1-2359-42E5-94EA-64862E697C4CQ37006888-0255605A-B71F-4FB3-A0E3-E61A79441A8FQ37327668-224B3585-9440-4228-B027-98D5DF6BD9C4Q37422625-290712C3-277B-47D5-9135-F1F513297AE9Q37687199-CF3DDFB7-6C76-4049-84A3-45BC5F990963Q38757854-8F113F26-49C5-4582-B326-F102B05C4687Q38991458-269EC573-CEC6-430C-8F7B-B42A7E28D4FDQ39096966-5B8EED37-6959-4DFC-8EB6-650B813ED739Q41339763-769C85F7-A5C8-4BE3-826E-C7B991D4D541Q41696304-9406DF0E-C215-4F3B-8056-BA921F5ABC05Q45325755-9BC60FC2-46EC-4A0B-A2B2-F0B52FF04092Q52620429-E59956E0-68D9-4E4A-9B71-1FE37DAA9012Q58551785-D7FF20B7-BC4D-4897-B2AC-90337D0CFFC1
P2860
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@ast
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@en
type
label
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@ast
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@en
prefLabel
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@ast
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@en
P2093
P2860
P356
P1476
Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
@en
P2093
Dan Theodorescu
Henry F Frierson
Marta Sanchez-Carbayo
Neveen Said
Rolf A Brekken
P2860
P304
P356
10.1172/JCI64782
P407
P577
2013-01-16T00:00:00Z